Metsera, A Wholly Owned Subsidiary Of Pfizer

This study tests a new drug called MET097 to help people with obesity or overweight lose weight. Participants receive weekly injections for 12 weeks, then switch to monthly doses for up to 64 weeks. The goal is to see if the drug is safe and effective compared to a placebo. About…

This study tests a new once-weekly injection called MET097 to help people with obesity or overweight lose weight. About 225 adults will receive either MET097 or a placebo for 28 weeks. The main goal is to see how much weight they lose compared to those on placebo.

This study tests a new drug called MET233, given as a weekly injection, to see if it is safe and how it works in adults who are overweight or have obesity but are otherwise healthy. About 120 participants will receive either the drug or a placebo for up to 12 weeks. The main goal…